PATENT CLAIM ANALYSIS

Application Number: 15926740
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "323000"]

Abstract:
Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administrations of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidin-2,6-dione in combination with 5-azacytidine.

Claim (Index 1):
A method of treating a myelodysplastic syndrome, which comprises administering to a patient having a myelodysplastic syndrome a therapeutically effective amount of 5-azacytidine, and a therapeutically effective amount of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 90.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13070761', '12777765', '13801262', '14517280', '11654550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7752543526821778
- 35 USC 102 Novelty (BERT): 0.5290138086724685
- Combined Prediction Score: 0.7506302982812069
- Mean Citation Score: 339.143926
- Max Citation Score: 355.8039
- Similarity Product: 324.7725666394472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test